rs137853229
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004260.4(RECQL4):c.2269C>T(p.Gln757*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,608,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000079 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00012 ( 0 hom. )
Consequence
RECQL4
NM_004260.4 stop_gained
NM_004260.4 stop_gained
Scores
3
1
Clinical Significance
Conservation
PhyloP100: 7.45
Genes affected
RECQL4 (HGNC:9949): (RecQ like helicase 4) The protein encoded by this gene is a DNA helicase that belongs to the RecQ helicase family. DNA helicases unwind double-stranded DNA into single-stranded DNAs and may modulate chromosome segregation. This gene is predominantly expressed in thymus and testis. Mutations in this gene are associated with Rothmund-Thomson, RAPADILINO and Baller-Gerold syndromes. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-144513412-G-A is Pathogenic according to our data. Variant chr8-144513412-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 6063.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-144513412-G-A is described in Lovd as [Pathogenic]. Variant chr8-144513412-G-A is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RECQL4 | NM_004260.4 | c.2269C>T | p.Gln757* | stop_gained | 14/21 | ENST00000617875.6 | NP_004251.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RECQL4 | ENST00000617875.6 | c.2269C>T | p.Gln757* | stop_gained | 14/21 | 1 | NM_004260.4 | ENSP00000482313.2 | ||
RECQL4 | ENST00000621189.4 | c.1198C>T | p.Gln400* | stop_gained | 13/20 | 1 | ENSP00000483145.1 | |||
RECQL4 | ENST00000534626.6 | c.633+4C>T | splice_region_variant, intron_variant | 5 | ENSP00000477457.1 | |||||
ENSG00000265393 | ENST00000580385.1 | n.272-194G>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152272Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
12
AN:
152272
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000117 AC: 28AN: 239722Hom.: 0 AF XY: 0.000106 AC XY: 14AN XY: 131968
GnomAD3 exomes
AF:
AC:
28
AN:
239722
Hom.:
AF XY:
AC XY:
14
AN XY:
131968
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000122 AC: 178AN: 1456590Hom.: 0 Cov.: 47 AF XY: 0.000110 AC XY: 80AN XY: 724868
GnomAD4 exome
AF:
AC:
178
AN:
1456590
Hom.:
Cov.:
47
AF XY:
AC XY:
80
AN XY:
724868
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152272Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74394
GnomAD4 genome
AF:
AC:
12
AN:
152272
Hom.:
Cov.:
33
AF XY:
AC XY:
6
AN XY:
74394
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
10
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 20, 2022 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 12734318, 10319867, 25120469, 18716613, 24635570, 21418107, 27247962, 33541411) - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | RECQL4: PVS1, PM3:Strong, PP1:Strong, PM2 - |
Rothmund-Thomson syndrome type 2 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | St. Jude Molecular Pathology, St. Jude Children's Research Hospital | Mar 24, 2022 | The RECQL4 c.2269C>T (p.Gln757Ter) change is a nonsense variant that is predicted to cause premature protein truncation and loss of normal protein function (PVS1). This variant has been reported in the homozygous or compound heterozygous state in multiple individuals with Rothmund-Thomson syndrome and RAPADILINO syndrome (PM3_verystrong; PMID: 8737976, 10319867, 21418107, 25120469, 18716613, 18616953, 12734318, 24635570, 27247962). It has also been reported in the heterozygous state in an individual with osteosarcoma (PMID: 31604778). This variant has a maximum subpopulation frequency of 0.040% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/variant/8-145738796-G-A?dataset=gnomad_r2_1). In summary, this variant meets criteria to be classified as pathogenic based on the ACMG/AMP criteria: PVS1, PM3_verystrong. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2009 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2021 | The c.2269C>T (p.Q757*) alteration, located in exon 14 (coding exon 14) of the RECQL4 gene, consists of a C to T substitution at nucleotide position 2269. This changes the amino acid from a glutamine (Q) to a stop codon at amino acid position 757. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from the Genome Aggregation Database (gnomAD) database, the RECQL4 c.2269C>T alteration was observed in 0.01% (32/271122) of total alleles studied, with a frequency of 0.04% (14/35144) in the Latino subpopulation. This recurrent mutation has been reported in the homozygous state and presumed in trans with other truncating alterations in patients with RECQL4-related disorders (Siitonen, 2009; Piard, 2015). Based on the available evidence, this alteration is classified as pathogenic. - |
Rothmund-Thomson syndrome;C0265308:Baller-Gerold syndrome;C1849453:Rapadilino syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Rothmund-Thomson syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Equipe Genetique des Anomalies du Developpement, Université de Bourgogne | May 02, 2014 | - - |
Baller-Gerold syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | This sequence change creates a premature translational stop signal (p.Gln757*) in the RECQL4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RECQL4 are known to be pathogenic (PMID: 12734318, 12952869). This variant is present in population databases (rs137853229, gnomAD 0.04%). This premature translational stop signal has been observed in individual(s) with RAPADILINO syndrome and Rothmund-Thomson syndrome (PMID: 10319867, 12734318, 18716613, 21418107, 24635570, 25120469, 27247962). ClinVar contains an entry for this variant (Variation ID: 6063). For these reasons, this variant has been classified as Pathogenic. - |
RECQL4-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 08, 2021 | Variant summary: RECQL4 c.2269C>T (p.Gln757X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 0.00012 in 239722 control chromosomes (gnomAD). c.2269C>T has been reported in the literature in multiple compound heterozygous and homozygous individuals affected with RECQL4-Related Disorders (e.g. Kitao_1999, Wang_2003, Siitonen_2009). These data indicate that the variant is very likely to be associated with disease. Three ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | curation | Sema4, Sema4 | Nov 09, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Benign
FATHMM_MKL
Pathogenic
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at